What is Vinblastine?
Vinblastine is a chemotherapeutic agent isolated from periwinkles. It is a plant alkaloid capable of blocking the reproduction and division of cells. The drug can prescribe this drug, usually as part of the chemotherapeutic regime with multiple medicines to slow down the spread of cancer and prevent them from growing. Patients will have to go to the infusion clinic for doses of vinblastin and the nurse will monitor the patient during treatment of any symptoms of side effects. Patients with histiocytosis can also benefit from vinblastin treatment. A nurse, physician or technician injection of the drug intravenously into a slowly moving infusion to give him time evenly circulating throughout the patient's body. Once the infusion is over, the patient may need to remain for monitoring to ensure that there is no reaction to the drug.
Vinblastine is a strong vesicant, causing blisters. If patients experience pain or notice redness and irritation around the injection site, they should immediately alert the person who gives the infuzi. It is possible that the needle could slip off the vein, allowing the drug to escape into the surrounding tissue. Patients should also report shortness of breath, rapid heart rate and rash, all signs of undesirable reactions to drugs.
The common side effects of vinblastin include nausea, hair loss, diarrhea, bone pain and vomiting. This drug will reduce the number of white blood cells in the body and cause fatigue and anemia. While patients are more vulnerable to infection on Vinblastin and should avoid living vaccines and people carrying infectious diseases. The patient may also be dangerous for minor colds, because the natural defense of the body is reduced. Drugs are also harmful to the development of fruits and women on this medicine should use contraceptive control to prevent pregnancy.
As a doctor treats a patient with vinblastin, the patient will need periodic checks for blood collection and study medical imaging. TheseThe tools are used to determine how well the patient reacts to treatment. Doctors can also discuss side effects to see if they are intolerable or disrupt the patient's ability to fight cancer. If necessary, the treatment plan can be modified to deal with side effects or low sensitivity to chemotherapy drugs. Alternative drugs may be available and clinical evaluation can be accessed if the patient does not respond to conventional treatment.